Skip to main navigation Skip to search Skip to main content

Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension

  • Visith Thongboonkerd
  • , Evelyne Gozal
  • , Leroy R. Sachleben
  • , John M. Arthur
  • , William M. Pierce
  • , Jian Cai
  • , Julie Chao
  • , Michael Bader
  • , Joao B. Pesquero
  • , David Gozal
  • , Jon B. Klein
  • University of Louisville School of Medicine
  • Max Delbrueck Center for Molecular Medicine and Charité- Universiätsmedizin Berlin
  • Federal University of São Paulo
  • Medical University of South Carolina
  • Robley Rex VA Medical Center
  • University of Louisville

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Abstract

Obstructive sleep apnea syndrome (OSAS), a disorder characterized by episodic hypoxia (EH) during sleep, is associated with systemic hypertension. We used proteomic analysis to examine differences in rat kidney protein expression during EH, and their potential relationship to EH-induced hypertension. Young male Sprague-Dawley rats were exposed to either EH or sustained hypoxia (SH) for 14 (EH14/SH14) and 30 (EH30/SH30) days. Mean arterial blood pressure was significantly increased only in EH30 (p < 0.0002). Kidney proteins were resolved by two-dimensional-PAGE and were identified by MALDI-MS. Renal expression of kallistatin, a potent vasodilator, was down-regulated in all animals. Expression of α-1-antitrypsin, an inhibitor of kallikrein activation, was up-regulated in EH but down-regulated in SH. Western blotting showed significant elevation of B2-bradykinin receptor expression in all normotensive animals but remained unchanged in hypertensive animals. Proteins relevant to vascular hypertrophy, such as smooth muscle myosin and protein-disulfide isomerase were up-regulated in EH30 but were down-regulated in SH30. These data indicate that EH induces changes in renal protein expression consistent with impairment of vasodilation mediated by the kallikrein-kallistatin pathway and vascular hypertrophy. In contrast, SH-induced changes suggest the kallikrein- and bradykinin-mediated compensatory mechanisms for prevention of hypertension and vascular remodeling. To test the hypothesis suggested by the proteomic data, we measured the effect of EH on blood pressure in transgenic hKLK1 rats that overexpress human kallikrein. Transgenic hKLK1 animals were protected from EH-induced hypertension. We conclude that EH-induced hypertension may result, at least in part, from altered regulation of the renal kallikrein system.

Original languageEnglish
Pages (from-to)34708-34716
Number of pages9
JournalJournal of Biological Chemistry
Volume277
Issue number38
DOIs
Publication statusPublished - 20 Sept 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension'. Together they form a unique fingerprint.

Cite this